The 11 coupregulated factors included PTPRC (a positive regulator of T-cell activation), IFI16 (a hematopoietic differentiation modulator), and SMARCE1 (a chromatin remodeler that enhances tumor suppressor accessibility). Here, PTPRC is linked to neoplasm.